Skip to main content
OpenTrials
Completed

NCT Number: NCT01775514

A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics

This non-interventional study will assess the occurrence rate of non-small cell lung cancer, colon cancer, breast cancer, gastric cancer and malignant melanoma in Turkey, and the diagnostic methods and treatments used. Data will be collected over 36 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Adana, Turkey (Türkiye)

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants diagnosed with non-small cell lung, colon, breast, gastric cancer and melanoma
  • Participants who give consent to the collection of their information after the first record and pathological confirmation of their cancer

Exclusion criteria

  • Participants not living in the city or representative region of the study center

Treatment and study plan

Primary outcomes

  1. Number of Participants with Malignant Melanoma (Occurrence Rate), Defined as New Cases Recorded in the Relevant Region in 1 Year/Population of the Region

    Time frame: 36 months

  2. Number of Participants with Non-Small Cell Lung Cancer (Occurrence Rate), Defined as New Cases Recorded in the Region in 1 Year Divided by (/) Population of the Region

    Time frame: 36 months

  3. Number of Participants with Colon Cancer (Occurrence Rate), Defined as New Cases Recorded in the Relevant Region in 1 Year/Population of the Region

    Time frame: 36 months

  4. Number of Participants with Breast Cancer (Occurrence Rate), Defined as New Cases Recorded in the Relevant Region in 1 Year/Population of the Region

    Time frame: 36 months

  5. Number of Participants with Gastric Cancer (Occurrence Rate), Defined as New Cases Recorded in the Relevant Region in 1 Year/Population of the Region

    Time frame: 36 months

Secondary outcomes

  1. Percentage of Participants Categorized by Tumor Size

    Time frame: 36 months

  2. Percentage of Participants Categorized by Histopathology Diagnosis

    Time frame: 36 months

  3. Percentage of Participants Categorized by the Staging System

    Time frame: 36 months

  4. Percentage of Participants Categorized by Surgery Type

    Time frame: 36 months

  5. Percentage of Participants Categorized by Type of Treatments Administered (ie, Adjuvant and Neoadjuvant Treatments)

    Time frame: 36 months

  6. Percentage of Participants With Metastasis Categorized by Treatment Regimens Used (ie, First-line, Second-line, Third-line, or Forth-line Chemotherapy)

    Time frame: 36 months

  7. Overall Survival (OS)

    Time frame: 36 months

  8. Progression-free Survival (PFS) as Assessed by Response Evaluation Criteria in Solid Tumors (RECIST)

    Time frame: 36 months

  9. Percentage of Participants With Family History of Cancer and Other Conditions

    Time frame: 36 months

  10. Percentage of Participants With History of Another Primary Cancer

    Time frame: 36 months

  11. Percentage of Participants Categorized by Diagnostic Methods

    Time frame: 36 months

  12. Percentage of Participants With Metastasis

    Time frame: 36 months

  13. Percentage of Participants Categorized by Tumor Localization

    Time frame: 36 months

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Occurrence Rate of Non-Small Cell Lung, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey & Diagnosis and Treatment Characteristics Turkish "Non-Small Cell Lung-Colon-Gastric-Breast (CGB) Cancer and Malignant Melanoma" Study

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jan 25, 2013
Registry last updated
Nov 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.